UroGen Pharma Ltd. (URGN) Revenue 2016–2025
UroGen Pharma Ltd. (URGN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$109.8MFY2025 · since FY2016: $17.5M → $109.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $109.8M | +21.4% |
| FY2024 | $90.4M | +9.3% |
| FY2023 | $82.7M | +28.5% |
| FY2022 | $64.4M | +34.0% |
| FY2021 | $48.0M | +307.2% |
| FY2020 | $11.8M | +65450.0% |
| FY2019 | $18,000 | -98.4% |
| FY2018 | $1.1M | -86.2% |
| FY2017 | $8.2M | -53.5% |
| FY2016 | $17.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice